GMED recently reported inline earnings but has now come to our attention on the possibility of a substantial breakout, it has also come to light that multiple Investment and Capital management firms have made significant acquisitions of the stock. This has brought it to the attention of many and has helped and will continue to propel the stock higher in our opinion. AVERAGE ANALYSTS PRICE TARGET $53 AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT P/E RATIO 35 SHORT INTEREST 3.4%
Official InvestorsHub (IHUB) Profile for TopMarketGainers.com. Since 2009, we are the #1 Source For #FREE Winning #NASDAQ & #NYSE-Listed Alerts!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.